Back to companies

Amneal Pharmaceuticals Inc: Premium Databases

Amneal Pharmaceuticals Inc Catalyst Calendar

Proactively evaluate Amneal Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Amneal Pharmaceuticals Inc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 20+ results. Subscribe to unlock more.
31 Dec 2021 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
21 Sep 2021 Phase I Trial Completion Amneal Pharmaceuticals Inc AMRX vigabatrin Central Nervous System Complex Partial Seizure; Epilepsy; Seizures Clinical Trial Registry
30 Apr 2021 Phase III Trial Completion Amneal Pharmaceuticals Inc AMRX (carbidopa + levodopa) Central Nervous System Parkinson's Disease Clinical Trial Registry
30 Oct 2020 Phase III Trial Completion Amneal Pharmaceuticals Inc; AstraZeneca Plc; KI Health Partners LLC AMRX; AZN zolmitriptan Central Nervous System Migraine Clinical Trial Registry
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer